Information technologySilicon Valley cash is still chasing blood despite Theranos bust | Bloomberg
Amid the collapse of Theranos last year, investors are betting that some of the disgraced blood-testing startup's lofty medical goals might still have a kernel of promise -- at other companies.
Medical devices and equipmentGates Foundation to invest up to $140 million in HIV prevention device | The Wall Street Journal
The Bill & Melinda Gates Foundation is investing as much as $140 million to support development of a tiny implantable drug pump it believes could help prevent people in sub-Saharan Africa and elsewhere from becoming infected with HIV, the virus that causes AIDS.
PharmaceuticalsNovartis joins forces with Ionis on cardiovascular treatments | Reuters
Novartis has agreed with Ionis Pharmaceuticals and its affiliate Akcea Therapeutics to license two experimental cardiovascular treatments in a deal which Ionis said could eventually be worth more than $1 billion.
Alexion says senior management improperly pressured staff to boost sales | The Wall Street Journal
Alexion Pharmaceuticals said Wednesday that senior management pressured staff to get customers to order its flagship drug earlier than needed to meet financial targets.
Safety, quality and clinical practiceRoom for improvement when young diabetics transition away from pediatricians | Reuters
A survey of young patients with type 1 diabetes shows that the process of transitioning away from care by pediatricians could be improved.